Novartis Investigative Site

Saint-Brieuc Cédex 22015

0 studies enrolling now · 2 studies all time

What they study most

HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer

Studies at this site

• A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi — Stopped early
• Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer — Completed